Note: The award owner's name is highlighted with blue.

 

 

Award in 2017

 

1.

 

Liang C, Peng S, Zhang BT, Lu Aiping, Zhang G. From precision medicine to drug discovery: inhibition of osteoblastic Smurf1 promotes bone formation in distinctive individuals with age-related osteoporosis. Webster Jee Young Investigator Award. 2017 ICMRS-ORS Membership Meeting, March 20, 2017. San Diego, California, USA.

2.

Yu Y, Li Y, Wu X, Li F, Lu A, Zhang G. An innovative gain-loss cell-SELEX strategy for development of a nucleic acid aptamer against PD-L1 for immunotherapy of triple negative breast cancer. Poster Abstract. Travel Award. Aptamer 2017, 11-12 April 2017. St. Hilda’s College, Oxford, UK

3.

Dang L, Shaikh AB. Osteoblastic Plekho1 contributes to articular inflammation and bone repair failure in rheumatoid arthritis. The third prize. The National Competition – Hong Kong Regional Final – Hong Kong University Student Innovation and Entrepreneurship Competition 2017, May 22-23 2017. Hong Kong, China

4.

Lu JLi FF, Liu J. Develop a Highly Water Soluble Nucleolin Aptamer Paclitaxel Conjugate with a Cathepsin Labile Linker for Tumor Specific Targeting in Ovarian Cancer. The second prize.  "Entrepreneurship Challenge Cup" - the National Competition - Hong Kong Regional Final, May 22-23 , 2017, Hong Kong, China

5.

Dang L. Research scholarship provided by the “Wai Tak Land Investment & Loan Co., Ltd.”, 2017

 

Award in 2016

 

1.

Liang C, Lu Aiping, Zhang G.   Oligopeptide aptamer-modified chalcone derivative specifically targets Smurf1   in osteoblasts and promotes bone formation.    Oral Abstract. Travel Award. Aptamers 2016, 04-05 April 2016. Hilda’s   College, Oxford, UK

2.

Liu J, Li D, Dang L, Lu A, Zhang   G. miR-214-3p targets TRAF3 to promote osteoclastic bone resorption during   the development of postmenopausal osteoporosis. ESCEO-AgNovos Healthcare   Young Investigator Awards, World Congress on Osteoporosis, Osteoarthritis and   Musculoskeletal Diseases, April 14 -17, 2016, Malaga, Spain.

3.

Dang L, Liu J, Li   D.F. A Delivery System Specifically Approaching Bone Resorption Surfaces   to Facilitate Therapeutic Modulation of MicroRNAs in   Osteoclasts.  1st Runner Up.  "Entrepreneurship   Challenge Cup" - China Competition - Hong Kong stage, 20-22 June,   2016, Hong Kong, China

4.

Wang L.Y., Liang C, Li F.F., Zhang   G, Lu A.P. Tumor cell-targeted delivery of CRISPR/Cas9 by   aptamer-functionalized lipopolymer for therapeutic genome editing of VEGF-A   in osteosarcoma. Oral Abstract. Webster Jee Travel Award, the 8th International   Conference on Osteoporosis and Bone Research, 19-22 October, 2016, Chong   Qing, China.

5.

Wu X.H., Liu   J, Xiao L.B., Lu A.P., Zhang G. Alterations of gut microbiome in rheumatoid   arthritis. Oral Abstract. Webster Jee Travel Award, the 8th International     Conference on Osteoporosis and Bone Research, 19-22 October, 2016,   Chong   Qing, China.

6.

Liang C, Peng   S, Zhang BT, Lu Aiping, Zhang G. Inhibition of osteoblastic Smurf1 promotes   bone formation in distinctive individuals with age-related osteoporosis. Oral   Abstract. Best Paper Award. 8th International Conference on Osteoporosis and   Bone Research, October 19-22, 2016, Chongqing, China.

 

Award in 2015

 

1.

Liang C.One-year   studentship provided by the “Mr. Kwok Yat Wai and Madam Kwok Chung Bo Fun   Graduate School Development Fund”, 2015.

2.

Liang C, Guo B, Wu H,   Zhang L, Lu A, Zhang G. Aptamer-functionalized delivery system for osteogenic   siRNAs to achieve osteoblast-specific RNA interference for bone anabolic   therapy. 2015 Orthopaedic Research Society (ORS) annual meeting, Las Vegas,   March 28-31, 2015. Certificate.

3.

Liu J, Dang L, Li D,   Guo B, Lu A, Zhang G. A delivery system specifically approaching bone   resorption surfaces to facilitate therapeutic modulation of miRNAs in   osteoclasts. Poster Abstract, Young Investigator Award, ICMRS Conference and   Xiangya Osteoporosis Forum, Changsha, China, Apr 9-11, 2015. Certificate

4.

Liang C, Xu M, Xu J, Zhang B, Lu A, Zhang G. Discovery of Small Molecules to   Promote BMP Signaling and Bone Formation. 6th Sino-American Symposium on   Clinical and Translational Medicine (SAS-CTM). Abstract. Clinical and   Translational Medicine Excellent Thesis Awards.

5.

Liang C, ASBMR Young Investigator Award for the European Calcified   Tissue Society (ECTS) Ph.D. Training Course. University of Siena, Tuscany,   Italy. September 13-16, 2015.

6.

Li D.F., Liu J, Guo B.S., Dang L, Liang C, Liu B, He B, He X.J.,   Liang Z.C., Lu A.P., Zhang G. Osteoclast-derived exosomal miR-214 inhibits   osteoblastic bone formation. ASBMR 2015 Annual Meeting. Oral Presentation.   Abstract. Young Investigator Award. October 9-12, 2015.

7.

Liu J, Li D.F., Guo B.S., Dang L, Lu A.P., Zhang G. Osteoclastic   miR-214 targets PTEN to increase bone resorption. ASBMR 2015 Annual Meeting.   Plenary Poster. Abstract. Young Investigator Travel Grant. October 9-12,   2015.

 

Award in 2014

 

1.

Zhang GeInvestigation of regulatory mechanism of ubiquitin   ligases and their  application in the treatment of osteoporosis. Chinese   Medical Science and Technology Award. (Second class). 2014.

2.

Zhang Ge. Investigation of   molecular function,   regulatory mechanism and disease correlation of ubiquitin ligases. Beijing   Science and Technology  Awards (First class). 2014. Certificate.

3.

Zhang Ge. Modernization of   traditional   anti-osteoporosis Chinese medicine. National Science   &   Technology Progress Award (Second class). 2014.  Certificate.

4.

Liang C, Guo B, Wu H,   Zhang L, Lu A, Zhang G.    Aptamer-Functionalized  Lipid Nanoparticles   (LNPs)   Targeting  Osteoblasts as a Novel RNA  Interference-Based Bone   Anabolic Strategy.   ASBMR 2014 Annual Meeting. Oral  Presentation     Abstract. Young  Investigator Award. September   12-15,  2014.

5.

Liang C, Guo B, Wu H,   Zhang L, Lu A, Zhang G.     Aptamer-Functionalized  Lipid Nanoparticles   (LNPs) Targeting     Osteoblasts as a Novel RNAi-Based Bone  Anabolic  Strategy.   5th   Sino-American Symposium on Clinical and Translational    Medicine   (SAS-CTM). Abstract. Clinical and Translational   Medicine  Excellent Thesis Awards.

6.

Dang L, Guo B, Li D,   Lu A, Zhang G. A    Peptide-functionalized delivery system to target   osteoclasts.   ASBMR 2014.  Poster Presentation Abstract. Young Investigator   Travel Grant Award.  September 11-15, 2014.

7.

Baosheng Guo, Liu Jin,   Dang   lei, Liang Chao,   Xiaohua Pan,  Lingqiang Zhang, Aiping Lu, Baoting Zhang, Ge Zhang.   Up-regulated CKIP-1 expression within osteoblasts associates with reduced BMP   signaling and  decreased   bone formation during aging, The   excellent thesis award. The   5th   Sino-American   Symosium on Clinical and  Translational   Medicine, May 31,     2014, Beijing. Certificate.

8.

Liang C, Guo B, Wu H,   Zhang L, Lu A, Zhang G.    Aptamer-Functionalized  Lipid   Nanoparticles (LNPs)   Targeting Osteoblasts  as a Novel RNAi-Based Bone  Anabolic   Strategy. Webster Jee Travel Award. the 7th  international    Conference on Osteoporosis and Bone Research, Oct 16-19,    Xiamen, China.

 

Award in 2013

 

1.

Jin Liu, Does  age-related increase in CKIP-1   within mesenchymal stem cells associate with  age-related impairment in   fracture repair ?, Oral Presentation Award (2nd Prize),    Postgraduate Research  Symposium on Regenerative Medicine 2013,   Guangzhou, China, 2013. Certificate.

2.                      

Biao LiuToward  targeted therapy in advanced   pancreatic cancer: a smart triptolide-nucleolin  aptamer    conjugate, Oral Presentation  Award (3nd Prize),    Postgraduate Research Symposium on Regenerative  Medicine 2013,    Guangzhou, China, 2013.  Certificate.

 

Dang L.Research scholarship provided by the “Wai Tak Land Investment & Loan Co., Ltd.”, 2017.

Copyright ©2016 - 2018 Law Sau Fai Institute for Advancing Translational Medicine in Bone & Joint Diseases